Posts with tag Biotech

As the development of vaccines against COVID-19 is progressing, the question becomes urgent who will be liable if a vaccine is marketed and will cause unexpected adverse effects as a result of the requested speed and scope of vaccine programmes. Pharmaceutical companies have requested to, inter alia, the EU that they be exempted from civil liability. They advocate that this be replaced by a compensation system that isn’t based on the presumption of any fault – a system that has been tested...